Ru, X. | Search bioRxiv

bioRxiv2018

Oncogenic activation of Nrf2 by specific knockout of Nrf1α that acts as a dominant tumor repressor

Liver-specific knockout of Nrf1 in mice leads to non-alcoholic steatohepatitis with dyslipidemia, and its deterioration results in spontaneous hepatoma, but the underlying mechanism remains elusive. A similar pathological model is herein reconstructed by using human Nrf1-specific knockout cell lines. We demonstrated that a marked increase of the inflammation marker COX2 in Nrf1-/- cells. Loss of Nrf1 leads to hyperactivation of Nrf2, which results from substantial decreases in both Keap1 and PTEN in Nrf1-/- cells. Further investigation of xenograft mice showed that malignant growth of Nrf1-/--derived tumor is almost abolished by silencing Nrf2, while Nrf1+/+-tumor is markedly repressed by inactive Nrf2-/-{Delta}TA, but unaffected by a priori constitutive activator of caNrf2{Delta}N. Mechanistic studies unraveled there exist opposing and unifying inter-regulatory cross-talks between Nrf1 and Nrf2. Collectively, Nrf1 manifests a dominant tumor-suppressive effect by confining Nrf2 oncogenicity, while Nrf2 can directly activate the transcriptional expression of Nrf1 to form a negative feedback loop.\n\nHIGHLIGHTSO_LIOpposing and unifying inter-regulatory cross-talks between Nrf1 and Nrf2\nC_LIO_LIMalignant growth of Nrf1-/--derived tumor is prevented by silencing Nrf2\nC_LIO_LIHyper-activation of Nrf2 by Nrf1-/- results from decreased Keap1 and PTEN\nC_LIO_LINrf1+/+-tumor is repressed by Nrf2-/-{Delta}TA, but unaltered by its active caNrf2{Delta}N\nC_LI

molecular biology↗

bioRxiv2018

Distinct isoforms of Nrf1 diversely regulate different subsets of its cognate target genes

The single Nrf1 gene has capability to be differentially transcripted alongside with alternative mRNA-splicing and subsequent translation through different initiation signals so as to yield distinct lengths of polypeptide isoforms. Amongst them, three of the most representatives are Nrf1, Nrf1{beta} and Nrf1{gamma}, but the putative specific contribution of each isoform to regulating ARE-driven target genes remains unknown. To address this, we have here established three cell lines on the base of the Flp-In T-REx system, which are allowed for tetracycline-inducibly stable expression of Nrf1, Nrf1{beta} and Nrf1{gamma}. The RNA-Sequencing results have demonstrated that a vast majority of differentially expressed genes (i.e. >90% DEGs detected) were dominantly up-regulated by Nrf1 and/or Nrf1{beta} following induction by tetracycline. By contrast, other DEGs regulated by Nrf1{gamma} were far less than those regulated by Nrf1/{beta} (i.e. ~11% of Nrf1 and 7% of Nrf1{beta}). Further transcriptomic analysis revealed that tetracycline-induced expression of Nrf1{gamma} significantly increased the percentage of down-regulated genes in total DEGs. These statistical data were further validated by quantitative real-time PCR. The experimental results indicate that distinct Nrf1 isoforms make diverse and even opposing contributions to regulating different subsets of target genes, such as those encoding 26S proteasomal subunits and others involved in various biological processes and functions. Collectively, Nrf1{gamma} acts as a major dominant-negative competitor against Nrf1/{beta} activity, such that a number of DEGs regulated by Nrf1/{beta} are counteracted by Nrf1{gamma}.

molecular biology↗